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Illicit drugsConcentrations ofmetabolites of illicit drugs in sewagewater can bemeasuredwith great accuracy and precision,
thanks to the development of sensitive and robust analytical methods. Based on assumptions about factors in-
cluding the excretion proﬁle of the parent drug, routes of administration and the number of individuals using
thewastewater system, the level of consumption of a drug can be estimated from suchmeasured concentrations.
When presenting results from these ‘back-calculations’, the multiple sources of uncertainty are often discussed,
but are not usually explicitly taken into account in the estimation process. In this paper we demonstrate how
these calculations can be placed in a more formal statistical framework by assuming a distribution for each pa-
rameter involved, based on a review of the evidence underpinning it. Using a Monte Carlo simulations approach,
it is then straightforward to propagate uncertainty in each parameter through the back-calculations, producing a
distribution for instead of a single estimate of daily or average consumption. This can be summarised for example
by a median and credible interval. To demonstrate this approach, we estimate cocaine consumption in a large
urban UK population, using measured concentrations of two of its metabolites, benzoylecgonine and
norbenzoylecgonine. We also demonstrate a more sophisticated analysis, implemented within a Bayesian statis-
tical framework using Markov chain Monte Carlo simulation. Our model allows the two metabolites to simulta-
neously inform estimates of daily cocaine consumption and explicitly allows for variability between days. After
accounting for this variability, the resulting credible interval for average daily consumption is appropriately
wider, representing additional uncertainty. We discuss possibilities for extensions to the model, and whether
analysis of wastewater samples has potential to contribute to a prevalence model for illicit drug use.
© 2014 The Authors. Published by Elsevier B.V.Open access under CC BY license.1. Introduction
The analysis of communal sewage water entering wastewater treat-
ment plants (WWTPs) offers potential for enhancing our knowledge of44 117 928 7325.
.
. Open access under CC BY license.illicit drug consumption (Daughton, 2001; Frost et al., 2008; van Nuijs
et al., 2011a; Zuccato et al., 2008). State-of-the-art sensitive and robust
analytical methods mean that concentrations of drug target residues
(DTRs), such as metabolites of an illicit drug, in wastewater can be mea-
sured with great accuracy and precision (Baker and Kasprzyk-Hordern,
2011b; Castiglioni et al., 2013). In what has been termed the ‘sewage ep-
idemiology’ approach, consumptionof the parent drug is ‘back-calculated’
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ample, our sister paper, entitled ‘Illicit andpharmaceutical drug consump-
tion estimated via wastewater analysis. Part A: Chemical analysis and
drug use estimates’ (Baker et al.,2014–in this issue), describes a study of
a large UK population.
The results of these calculations are of course only estimates of illicit
drug use, subject tomany sources of uncertainty. As theﬁeld develops, it
is important that this is properly addressed. Key variables include the
size of the population served by the WWTP and the percentage of a
dose of the parent drug that is excreted as the DTR. In addition, there
is evidence that this percentage varies according to the route of admin-
istration of the parent drug (Khan and Nicell, 2011). Hence data are also
required on the distribution of routes of administration across the pop-
ulation. All parameters informed by data are subject to sampling
variation.
Usually, as in Baker et al. (2014–in this issue), only the analytical
uncertainty in the measurement of DTR concentrations in a waste-
water sample has been explicitly taken into account. Since this uncer-
tainty is generally very small, back-calculated drug consumption
estimates often incorrectly appear to be very precise. To avoid
over-interpretation of the estimates, it is highly desirable to pres-
ent credible intervals around them, accounting for as many addi-
tional sources of uncertainty as possible. Recently, Lai et al.
(2011) and Mathieu et al. (2011) have attempted to propagate un-
certainty in multiple parameters simultaneously through the back-
calculations. However, as we will discuss below, their approach
has limited applicability.
In this paper we propose Monte Carlo simulation as a simple and
more general approach to accounting for multiple sources of uncertain-
ty in sewage epidemiology back-calculations. The approach involves
specifying a probability distribution, based on ‘all available evidence’,
for each of the parameters involved. The speciﬁed distributions are re-
peatedly sampled from at random, and the back-calculations performed
for each set of simulated values. The end result is a simulated distribu-
tion for consumption of the parent drug, fromwhich summary statistics
can be presented which appropriately reﬂect the uncertainties. Monte
Carlo simulation has been routinely used to propagate uncertainty in
models in the physical and social sciences since use of computers be-
came widespread (Metropolis and Ulam, 1949). It also has a key role
in decision making (Critchﬁeld and Willard, 1986; Doubilet et al.,
1985), as it provides a simple way of estimating expectations under
uncertainty in non-linear models. To demonstrate its application
to wastewater analysis, we use data from the Part A paper (Baker
et al.,2014–in this issue) to ‘back-calculate’ cocaine consumption
based on concentrations of the metabolites benzoylecgonine and
norbenzoylecgonine (Section 3).
A further possibility, which we illustrate in Section 4, is simula-
tion from a Bayesian joint posterior distribution using Markov
chain Monte Carlo (Gilks et al., 1996). This has the advantage of
combining simulation with statistical estimation of parameters
from multiple data sources. This approach – sometimes called
‘comprehensive decision analysis’ – has been popular in decision
sciences for over 30 years (Parmigiani, 2002; Samsa et al., 1999;
Spiegelhalter et al., 1999). For wastewater analysis, it opens up
possibilities for many more sophisticated statistical analyses, such
as modelling variability over time or allowing consumption of a
drug to be simultaneously informed by concentrations of multiple
DTRs.
2. Background: ‘back-calculation’ of drug consumption using
DTR concentrations
Baker et al. (2014–in this issue) present estimates of drug and
pharmaceutical consumption in a large (estimated 3.4 million) urban
UK population. They used the following modiﬁed versions
of formulae introduced by Zuccato et al. (2005) to estimate percapita consumption from measured DTR concentrations:
Load of DTR in grams grammes per day
Load ¼ Concentration Flow
1000
 100
100þ Stability
 
 100
100−Sorption
 
ð1Þ
whereConcentration = DTR concentration in wastewater inﬂuent
(ng/l),Flow = volume of ﬂow to the wastewater inﬂuent over a
24 hour period (millions of litres/day),Stability= percentage change in
concentration of the DTR in wastewater in the conditions (time, pH and
temperature) relevant to the study, and Sorption= percentage sorption
of the DTR to suspended particulate matter (SPM) in wastewater.
Estimated drug consumption in mg/day per 1000 people
Consumption ¼ Load
Population Excretion
 
MWPar
MWDTR
 
−OS ð2Þ
where Excretion = proportion of a dose of the parent drug excreted
as the DTR, MWPar = molecular weight of the parent compound,
MWDTR= molecular weight of the DTR, Population=size of the pop-
ulation served by the WWTP (millions), and OS= the amount of the
DTR present in wastewater due to sources other than consumption
of the parent compound (e.g. hospital or prescription usage).
For drugs such as cocaine that are administered using multiple
routes by different users, the typical metabolism proﬁle of the drug
will likely vary according to this. As such, Excretion should be estimated
as an average over the different routes (Khan and Nicell, 2011):
Proportion of a dose of the parent drug excreted as the DTR
Excretion ¼ ΣR
h
proportion of all parent drug mass that is administered by route Rð Þ
proportion of a dose of the parent drug excreted as the DTR
following administration by route RÞ
i
ð3Þ
Except for the molecular weights, there is uncertainty about all of
these parameters. Failure to take these uncertainties into account is like-
ly to lead to over-interpretation of the results.
When uncertainty about the individual parameter values involved
in the back-calculations has been quantiﬁed, it has generally been
expressed as relative standard deviations (SD) (Castiglioni et al.,
2013). The RSD is deﬁned as the standard deviation divided by the abso-
lute value of the parameter estimate. We note that there is ambiguity
here in the meaning of ‘standard deviation’. Consider, for example, the
Excretion factors in Eq. (3). Clearly the metabolism proﬁle of a drug
will vary across individuals, according for example to genetic factors.
This variability is quantiﬁed by the standard deviation. But for valid in-
ference on consumption by a large population, only the average excre-
tion proﬁle across the population of users need be well estimated. The
standard deviation of a parameter estimate is usually called the ‘stan-
dard error’ (SE) in statistics. The SE is the more appropriate measure-
ment of uncertainty about the parameter used in the back-calculation.
It can be reduced by the collection of new data, whereas the standard
deviation (SD) cannot. In the simple case where a parameter has
been estimated by the arithmetic mean of n data points, the SE is cal-
culated as SD=
ﬃﬃﬃ
n
p
. When the parameter estimate is a weighted aver-
age of estimates across multiple studies, then it is the standard error
of the pooled estimate that we generally require.
If the formulae for estimating consumption were linear on the log
scale, then the square of the RSD of the estimate of consumption could
be approximated by the sum of squares of the RSDs of each individual
parameter estimate (Lai et al., 2011; see also Mathieu et al. 2011 who
used this approach to quantify uncertainty in estimated loads). This
may have been a reasonable approach for early back-calculations,
when Stability, Sorption and OS were not accounted for and Excretion
was estimated by a single value rather than by averaging across routes
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timated by Eqs. (1)–(3) above is no longer a linear function of the un-
derlying parameters on the log scale. In addition, daily estimates of
consumption are often averaged over multiple days. As the calculations
rely on increasing numbers of parameters, and the function of parame-
ters being estimated becomes more complex, a more general approach
to accounting for uncertainty is required.
3. Propagation of uncertainty using Monte Carlo simulation
Monte Carlo simulation offers a simple and highly ﬂexible alterna-
tive to the approach of Lai et al. (2011). The ﬁrst stage is to characterise
each parameter in terms of a statistical distribution that reﬂects the un-
certainty about its value, based ideally on data, or on expert opinion if
no data are available. The choice of distribution should reﬂect the target
properties of the parameter and the distribution of any data informing it
(see e.g. Hunink, 2001, p351). For most parameters, uncertainty can be
represented using a normal distributionwithmean equal to the param-
eter estimate and standard deviation equal to the SE of that estimate. In
particular, if the parameter estimate is a sample mean then the normal
distribution can be considered appropriate by the Central Limit Theo-
rem, assuming that the sample is reasonably large. The distribution of
a proportion must of course lie entirely between 0 and 1. Therefore a
beta distribution, or a normal distribution on a logit scale, would be pre-
ferred, since either would enforce this constraint.
Values for the individual parameters are then simulated at random
from each of the assumed distributions, and the back-calculation
(Eqs. (1)–(3)) performed using these simulated values. This is repeated
many times, to obtain a simulated distribution for consumption of the
parent drug. The mean or median of these values serves as a point esti-
mate, while the 2.5th and 97.5th percentiles are a 95% credible interval
(Cr-I). This indicates the range in which there is a 95% probability that
the true value lies (assuming the distributions are accurate). The stan-
dard deviation of the simulated values represents our uncertainty
about the estimate of consumption, and can be interpreted as the SE
of the estimate. Note that these simulation-based results are themselves
subject to a degree of random sampling error, known as Monte Carlo
error. This is easily reduced by increasing the number of simulations.
As a demonstration, we will estimate cocaine consumption using
measured concentrations of the two metabolites benzoylecgonine and
norbenzoylecgonine, as presented by Baker et al. (2014–in this issue).
We show the daily measured concentrations of these two DTRs over
the sampling period in Table 1. In brief, a 24 hour composite sample of
wastewater was taken on each of seven days. Each daily sample was
split into two and analysed separately in order to assess analytical un-
certainty in measurement of metabolite concentration. The values re-
ported in Table 1 are mean concentrations across the two sub-samples
for each of the seven days, along with SEs of these means. Refer to
Baker et al. (2014–in this issue) for details of the sampling and analytical
methodology.We note that concentrations of these two cocainemetab-
olites across days are very highly correlated (sample correlation be-
tween mean daily concentrations = 0.95).
For this application, we will ignore the Sorption and OS factors
in Eqs. (1)–(2), since there is negligible sorption of benzoylecgonine
and norbenzoylecgonine to SPM (Baker et al.,2014–in this issue; Baker
and Kasprzyk-Hordern, 2011c) and other sources of these two metabo-
lites were assumed negligible. For Eq. (3) we assume that all cocaine
consumed by this population was administered by smoking or nasal in-
sufﬂation. The simpliﬁed equations for one metabolite are shown as a
‘directed acyclic graph’ (DAG) in Fig. 1. The arrows indicate the direction
of the ﬂow of information between parameters. We estimate per capita
cocaine consumption for each day separately, and also estimate average
consumption across the seven days of sampling. In the DAG, everything
within the rectangle relates to a speciﬁc day (d = 1,…,7) while pa-
rameters outside of the rectangle are assumed common across all
days.We use the same parameter estimates as Baker et al. (2014–in this
issue). Tables 1 and 2 show the distribution assumed for each parame-
ter, and brief descriptions of how the estimates and SEs were arrived
at. For the Excretion proportions relating to benzoylecgonine, results
from multiple small pharmacokinetic studies were available, a review
of these being presented by Khan and Nicell (2011) (see also
Castiglioni et al. (2013)). We calculated weighted averages across
these results using a simple technique known as meta-analysis (see,
for example, Borenstein, 2009). Results from multiple studies are also
available for Stability (Castiglioni et al., 2013; van Nuijs et al., 2012),
and could be averaged across in the same way. However, we deemed
it more appropriate to use the results from Baker and Kasprzyk-
Hordern (2011a), since we found no other results relating to the same
pH level, temperature and storage time. The population size estimate
was provided bywastewater personnel andwe unfortunately lacked in-
formation on how precise this might be. In this situation, it is better to
set the SE to allow for a reasonable degree of uncertainty rather than
to pretend that the parameter value was known exactly. We therefore
assumed a value for the SE such that the limits of a 95% conﬁdence inter-
val accommodated a 10% relative error in either direction (see Table 2).
We assumed a beta distribution for all proportions, in order to constrain
these to within the range [0,1]. The parameters of the beta distribution
can be estimated to correspond to the required means and SEs
(Table 2). We assumed a normal distribution for all other parameters.
It is straightforward to implement the Monte Carlo simulation ap-
proach in many software packages. Since the majority of readers will
be familiar with Excel, we provide an Excel spreadsheet that performs
the cocaine consumption estimation based on benzoylecgonine concen-
trations as an online appendix. However, models written in Excel lack
transparency, and it is easy tomake errors. In practice, we therefore en-
courage use of statistical software such as R, SPlus or Stata. Code for
performing the same analysis using R is therefore also provided in the
online materials.
In Fig. 2 we show daily estimates of cocaine consumption based on
independent analyses of the benzoylecgonine and norbenzoylecgonine
data, with the 95% Cr-Is reﬂecting all of the uncertainties described in
Tables 1 and 2 (the third set of estimates displayed will be explained
in Section 4). As is clear from the ﬁgure, the estimates based on the
twometabolites are very highly correlated, reﬂecting the high observed
correlation in measured concentrations. For 6 of the 7 days of sampling,
cocaine consumptionwas estimated to be slightly higher based onmea-
sured norbenzoylecgonine than benzoylecgonine concentrations. The
estimated mean daily cocaine consumption based on analysis of the
benzoylecgonine data was 1260 mg per 1000 people (95% Cr-I 1074 to
1494), compared with 1387 mg per 1000 people (95% Cr-I 932 to
2164) based on the norbenzoylecgonine data. The overlapping 95%
credible intervals, both for the mean and daily consumption estimates,
demonstrate that the two sets of results are however consistent with
each other.
The credible intervals based on norbenzoylecgonine concentrations
are considerably wider than those based on benzoylecgonine. This
reﬂects the fact that norbenzoylecgonine is a much more minor
metabolite of cocaine, with only about 1% of a typical dose being excret-
ed as it, compared with about 30% as benzoylecgonine. This means that
any uncertainties regarding excretion factors are magniﬁed to a greater
extent in the back-calculations (that is, the relative uncertainty is
larger).
4. Extended analysis using a Bayesian Markov chain Monte Carlo
simulation approach
A natural extension to the approach described in Section 3 is to com-
bine parameter estimation and uncertainty propagation in a single step,
which can be achievedwithin a Bayesian statistical framework comput-
ed using Markov chain Monte Carlo (MCMC) simulation (Gilks et al.,
1996). Like the Monte Carlo approach, MCMC involves repeatedly
Table 1
Daily measured ﬂow volumes and concentrations of benzoylecgonine and norbenzoylecgonine, with standard errors (SEs). SD denotes the standard deviation of measured values.
Mean SE of mean Source of information Distribution assumed for
parameter in back-calculations
Benzoylecgonine concentrations (ng per litre) Day 1 1068.29 15.47 For each day the reported measured concentration
is the mean over two samples. The SE is calculated
as SD=
ﬃﬃﬃ
2
p
.
Normal (mean, SE2)
Day 2 1054.89 22.89
Day 3 1167.18 24.91
Day 4 1544.00 27.96
Day 5 983.54 20.35
Day 6 1003.33 19.87
Day 7 907.00 6.65
Norbenzoylecgonine concentrations (ng per litre) Day 1 28.33 0.06
Day 2 33.59 0.69
Day 3 38.19 0.08
Day 4 53.95 0.64
Day 5 34.44 0.39
Day 6 31.08 0.57
Day 7 27.40 0.91
Flow volume (millions of litres) Day 1 1194.4 17.8 Flow was measured every 15 min and then averaged
for each day. The SE is SD=
ﬃﬃﬃ
n
p
where n = number of
ﬂow measurements in a day.
Normal (mean, SE2)
Day 2 1178.0 16.4
Day 3 1180.0 15.6
Day 4 1172.4 20.7
Day 5 1158.6 22.2
Day 6 1161.7 18.0
Day 7 1155.5 17.0
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making inferences based on summary statistics of simulated distribu-
tions. The distinction is that while in Monte Carlo simulation the distri-
bution of each parameter is completely pre-speciﬁed, in Bayesian
MCMC a ‘prior’ distribution is speciﬁed for each parameter, which is
updated to form a ‘posterior’ distribution based on the addition of
relevant new data to the model. Moving to full MCMC estimation,
which can be implemented using the WinBUGS software (Lunn et al.,
2000, 2012), opens up possibilities for a wide range of analyses. We
will use MCMC to extend our analysis of the UK cocaine example,Consumptiond
= (Loadd /(Population
x Excretion)) x
(MWc/MWm)
Mean daily consumption 
=
D
d
d=1
Consumption
D
Population
DAY d
Excretio
[(1-
L
(Conc
Flow
(100/(10
ps
Σ
Fig. 1.Directed acyclic graph for ‘back-calculation’ approach (singlemetabolite). Consumptiond=
thewastewater systemon day d (grammes); Population= size of the population served by theW
day d (ng/l); Flowd= total volume of ﬂow to the wastewater inﬂuent on day d (millions of litre
ditions relevant to the study; Excretion = proportion of consumed cocaine that is excreted as th
caine; ps = proportion of all cocaine mass that is smoked as free base, es = proportion of a do
dose of cocaine consumed by nasal insufﬂation that is excreted as the metabolite.allowing measured concentrations of the two metabolites to simulta-
neously inform estimates of daily consumption, and addressing day to
day variability.
Conceptually, the Bayesian approach involves reconsidering the di-
rection of relationships between the parameters described in Fig. 1. In
reality of course it is the amount of consumption of the parent drug
that, alongwith other parameters, determines loads and concentrations
of the DTRs— not the other way around. In Fig. 3 the ‘back-calculations’
(Eqs. (1) and (2)) are rewritten in themore natural ‘forwards’ formula-
tion in a new DAG, representing our extended analysis. The measuredFlowd
Stability
n=[ps x es] +
ps) x en]
oadd =
entrationd x
d /1000) x
0+Stability))
Concentrationd
en
es
cocaine consumption per 1000 people on day d (mg); Loadd= load ofmetabolite entering
WTP (millions); Concentrationd= concentration ofmetabolite in sample ofwastewater on
s); Stability = percentage change in concentration of metabolite in wastewater in the con-
e metabolite; MWm= molecular weight of metabolite; MWc = molecular weight of co-
se of cocaine smoked as free base that is excreted as the metabolite; en = proportion of a
Table 2
Details of the distributions assumed for parameters. SD = standard deviation, SE = standard error. For beta distributions, a = ((1 − Estimate) / SE2 − 1 / Estimate) × Estimate2 and
b = a × (1 / Estimate − 1).
Parameter Estimate SE of
estimate
Source of information Distribution assumed for
parameter in back-
calculations
Population: Size of population served by wastewater
treatment
plant (millions)
3.4 0.173 Population size estimate provided by water company
personnel. The amount of uncertainty is unknown.
Here we assume a 95% conﬁdence interval around
the estimate from 10% lower to 10% higher, implying
that SE = 0.2 × Estimate/(2 × 1.96)
Normal (Estimate, SE2)
ps: Proportion of cocaine consumed by the population
that smoked as free base
0.065 0.008 We examined the proportion of cocaine seized at police
stations that was crack cocaine, over the last ﬁve years
(Coleman, 2012). We used the mean of these ﬁve
proportions and the SE of this mean.
Beta (a, b)
es1: Proportion of a dose of cocaine smoked as free
base that is excreted as benzoylecgonine
0.087 0.009 We performed a ﬁxed effect meta-analysis of data presented
in Khan and Nicell (2011) from three small pharmacokinetic
studies.
Beta (a, b)
es2: Proportion of a dose of cocaine smoked as free
base that is excreted as norbenzoylecgonine
0.002 0.001 Data presented in Khan and Nicell (2011) from a single small
pharmacokinetic study (Cone et al., 1998).
Beta (a, b)
en1: Proportion of dose of cocaine taken by nasal
insufﬂation that is excreted as benzoylecgonine
0.316 0.020 We performed a random effects meta-analysis of data pre-
sented
in Khan and Nicell (2011) from six small pharmacokinetic
studies.
Beta (a, b)
en2: Proportion of dose of cocaine taken by nasal
insufﬂation that is excreted as norbenzoylecgonine
0.010 0.002 Data presented in Khan and Nicell (2011) from a single small
pharmacokinetic study (Cone et al., 1998).
Beta (a, b)
Stability1: Percentage increase in concentration of
benzoylecgonine in unﬁltered wastewater
5.5 2.1 Values from Baker and Kasprzyk-Hordern (2011a) for pH 7.4,
19 °C, 12 h. These were averages across two samples,
hence SE ¼ SD=
ﬃﬃﬃ
2
p
Normal (Estimate, SE2)
Stability2: Percentage increase in concentration of
norbenzoylecgonine in unﬁltered wastewater
3.5 4.3
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usually represented by a rectangle in a DAG. The data are realisations
of functions of multiple parameters, some of which we know about
and others (consumption of the parent drug) that we don't. For the pa-
rameters that we know about (excretion rates, population size, stability
and ﬂow), we can assume the same distributions as in Section 3. In
Bayesian modelling we refer to these as ‘informative’ prior distributions.
In contrast, daily consumption is unknown and is therefore assigned a
vague or ‘uninformative’ prior distribution. Consequently the posterior
distribution of consumption on each day is driven by the observed data.
A simplistic relationship between measurements on multiple DTRs
is illustrated in Fig. 3: here, daily cocaine consumption by theFig. 2. Estimated daily cocaine consumption in a large UK city, based on measured concentrat
‘back-calculation’ approach applied to each metabolite separately, with propagation of multi
and 95% Cr-I presented for each day is based on a fully Bayesian analysis of bothmetabolites sim
The standard deviation of consumption across days on the log scale (τ) was estimated to be 0.population, along with excretion factors, drives loads of each metab-
olite (m = 1,2) in the wastewater. In addition, a hierarchical model
structure (see e.g. Goldstein, 2011) is assumed for daily consumption
by the population. That is, the true amount of cocaine consumption is
allowed to vary across days, but these repeated measures are as-
sumed to be related through a common distribution. Speciﬁcally,
we assumed a common normal distribution for the logarithm of
daily per capita cocaine consumption, with mean μ and standard de-
viation τ. We chose to assume a normal distribution on the log scale
rather than the natural scale because estimates of cocaine consump-
tion based on the Monte Carlo simulation approach were clearly
right skewed. Estimation of average daily consumption from thisions of benzoylecgonine and norbenzoylecgonine. Estimates with 95% Cr-Is based on the
ple sources of uncertainty using Monte Carlo simulation (Section 3). The third estimate
ultaneously, with a commondistribution assumed for true daily consumptions (Section 4).
25 (95% Cr-I 0.14–0.57).
Flowd
Stabilitym
Concentrationmd
= (1000 x
Loadmd /Flowd)
x (100+Stabilitym)/100log(Consumptiond)
~N(µ,τ2)
µ
Population
DAY d
METABOLITE m
τ
Excretionm=[ps x esm]
+ [(1-ps) x enm]
ps
esm
enm
Measured
concentrations (m,d)
Loadmd =
Consumptiond
x Population x
Excretionm
x(MWm/MWc)
Fig. 3.Directed acyclic graph for Bayesian analysis of 2metabolites simultaneously. Consumptiond= cocaine consumption per 1000 people on day d (mg); Loadmd= load ofmetabolitem
entering thewastewater systemonday d (grammes); Population= size of thepopulation served by theWWTP (millions); Concentrationmd= concentration ofmetabolitem in sample of
wastewater on day d (ng/l); Flowd = total volume of ﬂow to the wastewater inﬂuent on day d (millions of litres); Stabilitym = percentage change in concentration of metabolite m in
wastewater in the conditions relevant to the study; Excretionm = proportion of consumed cocaine that is excreted as metabolite m; MWm = molecular weight of metabolite m;
MWc= molecular weight of cocaine; ps= proportion of all cocaine mass that is smoked as free base, esm= proportion of a dose of cocaine smoked as free base that is excreted as me-
tabolite m; enm = proportion of a dose of cocaine taken by nasal insufﬂation that is excreted as metabolite m.
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ulations (Section 3), accounts for the fact that there is more variation
between days than can be explained by measurement error.
We used WinBUGS to ﬁt the model described by Fig. 3. Vague prior
distributions were assumed for the parameters μ and τ. Posterior esti-
mates (medians) and 95% Cr-Is from this analysis are displayed in Fig. 2.
It can be seen that estimates of daily cocaine consumption are largely
driven by measured concentrations of benzoylecgonine. Incorporating
measurements of the more minor metabolite, norbenzoylecgonine, had
relatively little effect. Our model did not allow for correlations due to
the two metabolites having been measured in the same samples, or the
fact that the excretion factors for these metabolites were informed by
some of the same small pharmacokinetic studies. It is possible to allow
for complex correlation structures within the modelling approach (Ades
and Lu, 2003), but we considered this beyond the scope of our dem-
onstration. We note however that accounting for these sources of
correlation would lead to the norbenzoylecgonine measurements
having even less of an effect, since the amount of ‘extra’ information
in the norbenzoylecgonine data would appropriately be considered
less. This raises questions as to whether it is worthwhile monitoring
additional minor metabolites of a parent drug of interest.
Across the seven days of sampling, the estimated mean daily co-
caine consumption from the extended model was 1260 mg (95%
Cr-I 960–1662) per 1000 people. Note that this estimate is actually
identical to that from the simple Monte Carlo simulation analysis of
the benzoylecgonine data alone (Section 3). However, the credible
interval is wider, since the new analysis appropriately takes into ac-
count the evidence that cocaine consumption varies between days.
Since weekend peaks in consumption of many drugs (including
cocaine) are often observed (van Nuijs et al., 2011b), most likely due
to increased recreational drug use, it seems appropriate to incorporate
a ‘weekend effect’ into the model rather than assuming that consump-
tion on all days simply varies randomly around some mean. For exam-
ple, we might assume a mean of μ for consumption on the log scale on
weekdays, and of μ+ δ on weekends. Variability around these means
could be assumed either constant across all days or different on week-
ends. It would be straightforward to extend the WinBUGS model in
this way; however longer periods of data than were available for theUK study would clearly be required for reliable estimation of the week-
end effect.
Another natural extension to the model would be to allow some of
the other parameters in Fig. 3 to be informed by multiple sources of
data. For example, rather than placing an informative prior distribution
on an excretion rate, based on ﬁrst performing a meta-analysis of
data from multiple pharmacokinetic studies, we could perform the
meta-analysis directly within the Bayesian model. This would in-
volve reading themultiple estimates of excretion factors in as additional
data (adding additional rectangles representing data to the DAG). In
practice this would make little difference to the results, since standard
formulae exist for quantifying the uncertainty associated with a pooled
estimate from a meta-analysis. However, for some parameters the mul-
tiple relevant sources of information will have a more complex relation-
ship between them. For example, the relationship between stability data
frommultiple studies (Castiglioni et al., 2013; van Nuijs et al., 2012), re-
lating to different pH levels, temperatures and time windows, could be
explicitly modelled in order to gain a better estimate of stability in the
conditions of interest. Drug consumption modality could potentially be
informed simultaneously by population surveys, emergency room data
and drug treatment modality, in addition to police seizure data. Howev-
er, the parameters needed for the analysis are the proportions of cocaine
mass administered by different routes, not the proportions of users
reporting different modalities. Therefore the relationship between the
two would need to be formally described, involving additional parame-
ters relating to the average daily dosage of different types of user. To
combine over such data sources, with appropriate propagation of uncer-
tainty, we would recommend the Bayesian modelling approach.5. Uncertainty beyond statistical sampling error
We have demonstrated how uncertainty due to random sampling
error in each parameter estimate can be accounted for. However, it is
crucial to recognise that there is also potential for systematic error
(bias) in each parameter estimate. Since the amount of bias is unknown,
or not known precisely, this leads to additional uncertainty (Greenland,
2005)which is not reﬂected in the credible intervalswe have presented.
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WWTP personnel is almost certainly an estimate of the size of the resi-
dential population, which might be quite different from the size of the
population using the sewage system. The latter could perhaps vary con-
siderably even within a week, due to travel into and out of the city for
work, tourism and leisure purposes. In future studies it is desirable to
use hydrochemical parameters (Castiglioni et al., 2013) and/or uri-
nary biomarkers (Daughton, 2012) for more accurate estimation of
the population size, preferably providing estimates speciﬁc to each
day.
Another potential source of bias is in the excretion rates used. Al-
though these appear quite precise from the utilised standard errors
in Table 2 (low random error), they could however be biased esti-
mates of the true values (potential systematic error). Neither the
individuals studied nor the conditions (e.g. dosage) in the small
pharmacokinetic studies carried out to date are necessarily repre-
sentative of the population of interest. Improved pharmacokinetic
information therefore remains a priority for validity of sewage epi-
demiology back-calculations.
We included only two routes of administration of cocaine in our de-
monstrative analysis: smoking and nasal insufﬂation. The proportion of
cocaine that is smoked was estimated based on the proportion of all co-
caine seized that is crack cocaine, according to data reported by UK po-
lice (Coleman, 2012). However, this might not represent the truth well,
since seized cocaine is not a random sample of all consumed cocaine.
The proportion might also vary geographically and over time. In addi-
tion, both cocaine and crack can also be injected. The proportion of in-
jectors is likely to be very small in our population of interest, but it
will be important in future studies, particularly in some populations,
to account for injecting. With three or more routes of administration,
a Dirichlet distribution for the set of proportions would be appropriate,
since this automatically constrains their sum to equal one (Briggs et al.,
2003). The incorporation of multiple sources of data on drug modality
would be desirable, the potential for which we have noted in Section 4.
In this study, 24 hour composite time-proportional samples were
collected, involving sample collection every 15 min. To avoid bias in
estimated loads, it would be preferable to use ﬂow- or volume-
proportional samplingmodes (Castiglioni et al., 2013). Bias in estimated
loads could also arise from catchment-related characteristics including
exﬁltration and layout of theWWTP and sewer catchments. For further
discussion refer to Castiglioni et al. (2013) and Ort et al. (2010).
We have estimated daily cocaine consumption over seven days of
sampling in 2011, and the average consumption over these 7 days.
However, only one of the days was on a weekend (there was no sample
on Sunday). Since we would expect a weekend peak in drug consump-
tion, the average consumption over these seven days is likely to be a
slight underestimate of the consumption over a calendar week. Even if
we had seven consecutive days of sampling, extrapolation of ﬁndings
to the whole of 2011 could not be justiﬁed, since we would have no
idea whether those particular seven days were representative of the
year. For example, holidays, parties or discovery of illicit drug produc-
tion facilities could lead to bias. In Brussels, van Nuijs et al. (2011b)
have, by analysing daily samples over a period of eight months,
demonstrated signiﬁcant differences in loads of DTRs including
benzoylecgonine both between days and between months. More
detailed study of temporal variation is clearly required before
making generalisations outside of the sampling period.
We emphasise that what we are describing here are potential prob-
lemswith the quality of someof the current data, rather than limitations
of the statistical modelling approaches described. Aswe have discussed,
bias might be reduced by obtaining better quality data, or by allowing
multiple sources of data to inform a parameter. Alternatively, if the like-
ly bias can be quantiﬁed using a distribution then this could be incorpo-
rated into themodel (Eddy et al., 1992; Greenland, 2005). For example,
by modelling more detailed data from elsewhere (e.g. van Nuijs et al.,
2011b), itwould be possible to deﬁne a distribution describing the likelysize of bias associated with measuring samples over only a seven day
period when what we are interested in is, say, a year. This distribution
could then be incorporated into the statistical analysis. Similarly, the
likely degree of a weekend peak in consumption might be quantiﬁed
and incorporated, based either on published results or new modelling
of other data sets.
6. Conclusions and discussion
We have proposed and demonstrated use of a Monte Carlo simula-
tions approach to account for multiple sources of uncertainty when es-
timating illicit drug consumption using wastewater data. The approach
produces credible intervals thatmore appropriately reﬂect the degree of
uncertainty around estimates of drug consumption. To aid researchers
in implementing this approach in future studies, we have provided
web appendices demonstrating how this can be done. However, as
the ﬁeld develops further, it seems likely that extensions to the ap-
proach will increasingly be required. We have demonstrated two
such extensions in Section 4, implemented within a Bayesian frame-
work using MCMC simulation. We emphasise that this requires use
of specialist software, and would highly recommend involvement
of a statistician.
We have highlighted the importance of the distinction between
standard deviations and standard errors. This distinction is crucial
whatever approach is used to account for uncertainties. For example,
consider the ‘RSD’ relating to excretion of cocaine as benzoylecgonine
following nasal insufﬂation. From Table 2 we estimate this to be 0.02/
0.316 = 6%. This is much smaller than the RSD of 25% reported by
Castiglioni et al. (2013) for this parameter, on the basis of very similar
data. This is because the latter incorporates inherent variability in excre-
tion factors across individuals, which we have argued is not relevant to
the estimation of average consumption.
The other crucial distinction we have made is that of uncertainty
that is the result of statistical sampling error, and uncertainty due to
systematic error (bias). We have made suggestions for how bias
might be reduced or accounted for. However, it is important to real-
ise that for some parameters the ideal is unlikely to ever be reached:
for example, large scale pharmacokinetic studies across a range of
routes of administration and doses, and in representative samples
of drug users, seem unlikely due to the considerable costs and ethi-
cal issues.
In this paper we have focused on the ambitious target of accurately
estimating absolute consumption of a drug by some population. In this
context, all of the sources of uncertainty discussed are important. How-
ever, if instead examining trends over time (van Nuijs et al., 2011b) or
across places (Banta-Green et al., 2009; Thomas et al., 2012) then
some uncertainties appear less important. For example, Baker et al.
(2014–in this issue) noted that 6-acetylmorphine lacks potential
for estimation of absolute heroin usage, because of low and uncer-
tain excretion rates. But if the aim of the research was to examine
relative trends in heroin consumption over time in a stable popula-
tion, then arguably this uncertainty might be of little relevance.
Care would however be required to sample in a consistent manner,
and to control for changes in the size and characteristics of the pop-
ulation. As we have noted, the size of the population served by an
urban wastewater treatment plant is likely to vary even during a
week. Average excretion factors might well also vary over a long pe-
riod and across places, due to changes or differences in routes of ad-
ministration or ethnic diversity.
An important research question is whether the information pro-
vided by wastewater analysis has the potential to contribute to es-
timates of the prevalence of illicit drug use. It has been noted
previously that wastewater analysis is unlikely to replace more
conventional approaches (Baker et al., 2014–in this issue; Frost
et al., 2008). However, it is also well known that these conventional
approaches lack a strong evidence base (Hickman et al., 2003).
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drugs such as Cannabis, and will severely underestimate the use
of rarer and more marginal drugs such as heroin, crack cocaine,
and injecting behaviour. ‘Indirect’ estimation techniques such as
capture–recapture or multiplier methods are therefore often used
instead (e.g. Hickman et al., 2004; Kimber et al., 2008; King et al.,
2009). However, these methods rely on untestable assumptions
that might often be violated (Jones et al., in press) and different ap-
proaches can provide inconsistent estimates of prevalence
(Singleton and Britain, 2006).
A Bayesian ‘multi-parameter evidence synthesis’ (MPES) framework
(Ades et al., 2008;Hickman et al., 2013)would allowmultiple sources of
evidence on prevalence to be combinedwithin a singlemodel. The basic
concept is the same as that described in Section 4: multiple sources of
data are allowed to simultaneously inform particular parameters. With-
in such amodel, information on drug use can also be related to informa-
tion on relevant drug harms, such as drug-related mortality, so that
information on both sides (prevalence and harm) can be used simul-
taneously to validate the other and generate coherent estimates
(Hickman et al., 2013).
To incorporate wastewater data into such a model, the relationship
between prevalence and consumption would need to be speciﬁed. A
major challenge here is that there are several sub-populations of illicit
drug users (recreational/dependent, mono/poly-drug users and, for co-
caine, powder/crack cocaine users). Generally the focus of indirect
methods such as capture–recapture is on estimating the number of
problematic drug users, such as regular users of crack cocaine. For
meaningful incorporation of the two types of data into a single model,
estimates of the relative size of the different sub-populations, and of
the average daily consumption of members of each group, would be re-
quired. Another aspect requiring careful consideration is the likely lack
of alignment of geographical boundaries used across the different
methods. It is uncertain whether these challenges could be adequately
overcome. In addition, both types of analyses rely on a large number
of assumptionswithmultiple uncertainties, and the ﬂow of information
around such networks of evidence is complex. Where an estimate
depends on several uncertain parameters, reduction of uncertainty
in part of the model has little impact on the ﬁnal credible interval
of interest unless it was the most uncertain parameter. This means
that it is technically possible that incorporating wastewater data
into such a model might lead to a reduction in uncertainty about,
for example, routes of administration or average dosage, rather
than about prevalence. As such, while there is little doubt that com-
bining information fromwastewater analysis and from epidemiolog-
ical studies is computationally possible, it remains to be seen whether
this would be worthwhile.
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